Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
29,433,678
-
Shares change
-
+240,348
-
Total reported value, excl. options
-
$346,422,270
-
Value change
-
+$3,332,219
-
Put/Call ratio
-
83%
-
Number of buys
-
58
-
Number of sells
-
43
-
Price
-
$11.77
Institutional Holders of Kiniksa Pharmaceuticals Intern - COM (KNSA) as of Q4 2021
As of 31 Dec 2021 Kiniksa Pharmaceuticals Intern - COM (KNSA) had 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 29,433,678 shares of stock of the company.
Largest 10 holders included PICTET ASSET MANAGEMENT SA, BlackRock Inc., HHLR ADVISORS, LTD., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, STATE STREET CORP, ArrowMark Colorado Holdings LLC, Hudson Bay Capital Management LP, Opaleye Management Inc., and RICE HALL JAMES & ASSOCIATES, LLC.
This table shows 129 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.